Oligodendroglioma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Oligodendroglioma
NCT00831324: Everolimus in Treating Patients With Recurrent or Progressive Low-Grade Glioma

Recruiting
2
60
US
everolimus, immunohistochemistry staining method, laboratory biomarker analysis
University of California, San Francisco
Brain Tumor
01/16
01/17

Download Options